Načítá se...
A case of castration-resistant prostate cancer with liver metastases achieved a complete response by docetaxel chemotherapy
Castration-resistant prostate cancer (CRPC) patients with liver metastases have an extremely poor prognosis. Herein, we report a rare patient who achieved a complete response by docetaxel chemotherapy for this aggressive disease. A 67-year-old Japanese male diagnosed with local prostate cancer [init...
Uloženo v:
| Vydáno v: | Transl Androl Urol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7215045/ https://ncbi.nlm.nih.gov/pubmed/32420190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2020.01.20 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|